Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Santander-Ortega MJ"'
Autor:
Sáez-González L; NUTRISAF Research Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Carreño-Díaz M; DEVANA Research Group, Pharmaceutical Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), 02008 Albacete, Spain., Blázquez-Abellán G; NUTRISAF Research Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Santander-Ortega MJ; DEVANA Research Group, Pharmaceutical Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), 02008 Albacete, Spain., Martínez-García RM; NUTRISAF Research Group, Departamento de Enfermería, Fisioterapia y Terapia Ocupacional, Facultad de Enfermería, University of Castilla-La Mancha, 16071 Cuenca, Spain., Martínez LA; NUTRISAF Research Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Carbajal JA; NUTRISAF Research Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Castro-Vázquez L; NUTRISAF Research Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain.
Publikováno v:
Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2024 Nov 08; Vol. 13 (11). Date of Electronic Publication: 2024 Nov 08.
Autor:
González-Fuentes J; Development and Evaluation of Nanomedicines (DEVANA), Faculty of Pharmacy, Albacete, Spain.; Instituto de Biomedicina (IB), Universidad de Castilla-La Mancha (UCLM), Albacete, 02008, Spain., Plaza-Oliver M; Development and Evaluation of Nanomedicines (DEVANA), Faculty of Pharmacy, Albacete, Spain.; Instituto de Biomedicina (IB), Universidad de Castilla-La Mancha (UCLM), Albacete, 02008, Spain., Santander-Ortega MJ; Development and Evaluation of Nanomedicines (DEVANA), Faculty of Pharmacy, Albacete, Spain. manuel.santander@uclm.es.; Instituto de Biomedicina (IB), Universidad de Castilla-La Mancha (UCLM), Albacete, 02008, Spain. manuel.santander@uclm.es., Lozano MV; Development and Evaluation of Nanomedicines (DEVANA), Faculty of Pharmacy, Albacete, Spain. mvictoria.lozano@uclm.es.; Instituto de Biomedicina (IB), Universidad de Castilla-La Mancha (UCLM), Albacete, 02008, Spain. mvictoria.lozano@uclm.es.
Publikováno v:
Drug delivery and translational research [Drug Deliv Transl Res] 2024 Oct; Vol. 14 (10), pp. 2598-2614. Date of Electronic Publication: 2024 Jun 10.
Autor:
Plaza Oliver M; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States.; Development and Evaluation of Nanodrugs (DEVANA) Group, Faculty of Pharmacy and Biomedicine Institute at University of Castilla-La Mancha, 02008 Albacete, Spain.; Castilla-La Mancha Health Research Institute (IDISCAM), 02071 Albacete, Spain., Gardner E; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Lin T; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Sheehan K; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Sperry MM; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Lightbown S; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Martínez MR; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Del Campo D; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Fotowat H; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Lewandowski M; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Takeda T; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., C Pauer A; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Kaushal S; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Gnyawali V; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Lozano MV; Development and Evaluation of Nanodrugs (DEVANA) Group, Faculty of Pharmacy and Biomedicine Institute at University of Castilla-La Mancha, 02008 Albacete, Spain.; Castilla-La Mancha Health Research Institute (IDISCAM), 02071 Albacete, Spain., Santander Ortega MJ; Development and Evaluation of Nanodrugs (DEVANA) Group, Faculty of Pharmacy and Biomedicine Institute at University of Castilla-La Mancha, 02008 Albacete, Spain.; Castilla-La Mancha Health Research Institute (IDISCAM), 02071 Albacete, Spain., Novak R; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Super M; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States., Ingber DE; Wyss Institute for Biologically Engineering at Harvard University, Boston, Massachusetts 02215, United States.; Vascular Biology Program & Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, United States.; Harvard John A. Paulson School of Engineering and Applied Sciences, Boston, Massachusetts 02134, United States.
Publikováno v:
ACS nano [ACS Nano] 2024 Sep 03; Vol. 18 (35), pp. 23991-24003. Date of Electronic Publication: 2024 Aug 21.
Autor:
Marcos-Rabal P; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., González-Fuentes J; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Castro-Vázquez L; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Lozano MV; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Rodríguez-Robledo V; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Santander-Ortega MJ; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Selva-Clemente J; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Villaseca-González N; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Del Mar Arroyo-Jiménez M; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain.
Publikováno v:
Current pharmaceutical design [Curr Pharm Des] 2021 Oct 05; Vol. 27 (30), pp. 3305-3336.
Autor:
Castro-Vázquez L; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Rodríguez-Robledo V; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Plaza-Oliver M; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Santander-Ortega MJ; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Victoria Lozano M; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., González J; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Villaseca N; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Marcos P; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain., Mar Arroyo-Jiménez M; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N C.P, 02008 Albacete, Spain.
Publikováno v:
Journal of food science and technology [J Food Sci Technol] 2021 Oct; Vol. 58 (10), pp. 4034-4044. Date of Electronic Publication: 2021 Jan 05.
Autor:
Castro-Vázquez L; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Lozano MV; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Rodríguez-Robledo V; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., González-Fuentes J; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Marcos P; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Villaseca N; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Arroyo-Jiménez MM; Analytical Chemistry and Food Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain., Santander-Ortega MJ; Pharmaceutical Technology Area, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), Avda. Doctor Jose María Sanchez Ibañez. S/N c.p., 02008 Albacete, Spain.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2021 Sep 30; Vol. 26 (19). Date of Electronic Publication: 2021 Sep 30.
Autor:
Plaza-Oliver M; Faculty of Pharmacy, Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, 02008, Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008, Albacete, Spain., Santander-Ortega MJ; Faculty of Pharmacy, Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, 02008, Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008, Albacete, Spain., Lozano MV; Faculty of Pharmacy, Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, 02008, Albacete, Spain. mvictoria.lozano@uclm.es.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008, Albacete, Spain. mvictoria.lozano@uclm.es.
Publikováno v:
Drug delivery and translational research [Drug Deliv Transl Res] 2021 Apr; Vol. 11 (2), pp. 471-497. Date of Electronic Publication: 2021 Feb 02.
Autor:
Santalices I; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Vázquez-Vázquez C; Department of Physical Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Santander-Ortega MJ; Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain., Lozano V; Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain., Araújo F; Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal., Sarmento B; Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.; Instituto de Investigacão E Formacão Avançada Em Ciências E Tecnologias da Saúde (CESPU), 4585-116, Gandra, Portugal., Shrestha N; Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium., Préat V; Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium., Chenlo M; Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain., Alvarez CV; Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain., Benetti F; ECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy., Cuñarro J; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Tovar S; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Torres D; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.
Publikováno v:
Drug delivery and translational research [Drug Deliv Transl Res] 2021 Apr; Vol. 11 (2), pp. 524-545. Date of Electronic Publication: 2021 Feb 11.
Autor:
Santalices I; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Vázquez-Vázquez C; Department of Physical Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Santander-Ortega MJ; Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain., Lozano V; Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain., Araújo F; Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal., Sarmento B; Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.; Instituto de Investigacão E Formacão Avançada Em Ciências E Tecnologias da Saúde (CESPU), 4585-116, Gandra, Portugal., Shrestha N; Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium., Préat V; Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium., Chenlo M; Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain., Alvarez CV; Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain., Benetti F; ECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy., Cuñarro J; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Tovar S; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Torres D; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.
Publikováno v:
Drug delivery and translational research [Drug Deliv Transl Res] 2021 Apr; Vol. 11 (2), pp. 546.
Autor:
Plaza-Oliver M; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), 02071 Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008 Albacete, Spain., Cano EL; Quantitative Methods and Socio-economic Development Group, Institute for Regional Development (IDR), University of Castilla-La Mancha (UCLM), 02006 Albacete, Spain.; Data Science laboratory, Rey Juan Carlos University, 28933 Madrid, Spain., Arroyo-Jimenez MM; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), 02071 Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008 Albacete, Spain., Gámez M; Quantitative Methods and Socio-economic Development Group, Institute for Regional Development (IDR), University of Castilla-La Mancha (UCLM), 02006 Albacete, Spain., Lozano-López MV; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), 02071 Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008 Albacete, Spain., Santander-Ortega MJ; Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha (UCLM), 02071 Albacete, Spain.; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), 02008 Albacete, Spain.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2021 Mar 10; Vol. 13 (3). Date of Electronic Publication: 2021 Mar 10.